Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001602462-17-000001
Filing Date
2017-06-27
Accepted
2017-06-27 13:13:56
Documents
1
Effectiveness Date
2017-06-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10814
  Complete submission text file 0001602462-17-000001.txt   11879
Mailing Address 800 FIFTH AVENUE STE. 4100 SEATTLE WA 98104
Business Address 800 FIFTH AVENUE STE. 4100 SEATTLE WA 98104 (206) 447-1455
KinDex Pharmaceuticals, Inc. (Filer) CIK: 0001602462 (see all company filings)

EIN.: 270767031 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-269780 | Film No.: 17931804